The engineering of monoclonal antibodies has created a new generation of pharmaceuticals with the desired pharmacokinetics and biodistribution properties. For radioimmunotherapy and radioscintigraphy, optimum tumor targeting can be achieved using engineered constructs that provide high antigen affin
β¦ LIBER β¦
Genetically engineered antibodies
β Scribed by Michael A Boss; Clive R Wood
- Publisher
- Elsevier Science
- Year
- 1985
- Tongue
- English
- Weight
- 172 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0167-5699
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Pharmacokinetics and biodistribution of
β
Surinder K Batra; Maneesh Jain; Uwe A Wittel; Subhash C Chauhan; David Colcher
π
Article
π
2002
π
Elsevier Science
π
English
β 70 KB
Genetically engineered kidneys
β
Adrian S. Woolf; Leon G. Fine
π
Article
π
1993
π
Springer
π
English
β 655 KB
Novel Genetically Engineered Tetracenomy
β
Dr. Heinrich Decker; Dipl.-Biol. Sabine Haag; Dipl.-Ing. GyΓΆrgyi Udvarnoki; Priv
π
Article
π
1995
π
John Wiley and Sons
π
English
β 523 KB
Genetically Engineered Microbial Fuel Ce
β
Lital Alfonta
π
Article
π
2010
π
John Wiley and Sons
π
English
β 754 KB
## Abstract This article reviews the advances that were made towards the understanding and the improvement of electron transfer and communication between living cells and electrodes with a specific emphasis on microbial fuel cells and bioelectrical systems. It summarizes the efforts that were made
Commercialization of genetically enginee
β
Roy L. Fuchs; Frederick J. Perlak
π
Article
π
1992
π
Elsevier Science
π
English
β 493 KB
A genetically engineered mosquitocidal c
β
S. Edward Stevens; Randy C. Murphy; William J. Lamoreaux; Lewis B. Coons
π
Article
π
1994
π
Springer
π
English
β 817 KB